In NSCLC, TREM-1 expression in tumors was restricted to tumor-infiltrating CD68+ myeloid cells (64), yet soluble TREM-1 in serum was also reported to have prognostic significance (66). This evidence concerns the gene CD68 and non-small cell lung carcinoma.